8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Mar 4, 2026·SEC
Material company update
Nov 26, 2025·SEC
Alto Ingredients, Inc.(ALTO)Earnings, Financials & Key Ratios
ALTO•NASDAQ
$5.56
$430M mkt cap·34.8× P/E·Price updated May 6, 2026
SectorBasic MaterialsIndustrySpecialty ChemicalsSub-IndustryIngredients, pigments and specialty minerals
AboutAlto Ingredients, Inc. produces and markets specialty alcohols and essential ingredients in the United States. The company operates in three segments: Marketing and Distribution, Pekin Production, and Other Production. It offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners for health, home, and beauty markets; grain neutral spirits used in alcoholic beverages, flavor extracts, and vinegar, as well as corn germ used in corn oils and carbon dioxide for food and beverage markets; and essential ingredients include dried yeast, corn gluten meal, corn gluten feed, distillers grains, and liquid feed for commercial animal feed and pet food applications. The company also provides fuel-grade ethanol used as transportation fuel and distillers corn oil used as a biodiesel feedstock, as well as fuel-grade ethanol produced by third parties. In addition, it offers transportation, storage, and delivery services through third-party service providers. The company sells ethanol to integrated oil companies and gasoline marketers; essential ingredient feed products to dairies and feedlots; and corn oil to poultry and biodiesel customers. It operates five alcohol production facilities, including three plants in the Midwestern states of Illinois; and two facilities located in the Western states of Oregon and Idaho. The company was formerly known as Pacific Ethanol, Inc. and changed its name to Alto Ingredients, Inc. in January 2021. Alto Ingredients, Inc. was founded in 2003 and is headquartered in Pekin, Illinois.Show more
- Revenue$918M-4.9%
- EBITDA$33M+220.7%
- Net Income$13M+122.6%
- EPS (Diluted)0.16+119.5%
- Gross Margin3.8%+277.6%
- EBITDA Margin3.59%+227.0%
- Operating Margin0.84%+115.7%
- Net Margin1.45%+123.8%
- ROE5.67%+124.3%
- ROIC1.86%+115.8%
- Debt/Equity0.40-21.9%
- Interest Coverage0.72+110.7%
ALTO Key Insights
Alto Ingredients, Inc. (ALTO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 98 (top 2%)
- ✓Efficient asset utilization: 2.4x turnover
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ALTO Price & Volume
Alto Ingredients, Inc. (ALTO) stock price & volume — 10-year historical chart
Loading chart...
ALTO Growth Metrics
Alto Ingredients, Inc. (ALTO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-2.57%
5 Years0.46%
3 Years-11.75%
TTM-4.9%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM122.61%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM119.76%
Return on Capital
10 Years-4.76%
5 Years-4.59%
3 Years-5.95%
Last Year2.29%
ALTO Recent Earnings
Alto Ingredients, Inc. (ALTO) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
Mar 4, 2026EPS
$0.19
Est $0.02
+850.0%
Revenue
$232M
Est $235M
-1.2%
Q4 2025
Nov 5, 2025EPS
$0.19
Est $0.06
+416.7%
Revenue
$241M
Est $235M
+2.6%
Q3 2025
Aug 6, 2025EPS
$0.15
Est $0.18
+16.7%
Revenue
$218M
Est $224M
-2.3%
Q2 2025
May 7, 2025EPS
$0.16
Est $0.15
-6.7%
Revenue
$227M
Est $222M
+2.0%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 4, 2026 | $0.19vs $0.02+850.0% | $232Mvs $235M-1.2% |
| Q4 2025 | Nov 5, 2025 | $0.19vs $0.06+416.7% | $241Mvs $235M+2.6% |
| Q3 2025 | Aug 6, 2025 | $0.15vs $0.18+16.7% | $218Mvs $224M-2.3% |
| Q2 2025 | May 7, 2025 | $0.16vs $0.15-6.7% | $227Mvs $222M+2.0% |
Based on last 12 quarters of dataView full earnings history →
ALTO Peer Comparison
Alto Ingredients, Inc. (ALTO) competitors in Ingredients, pigments and specialty minerals — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 REX | 1.58B | 48.02 | 29.10 | -22.91% | 7.73% | 7.67% | 0.03 | |
 GPRE | 1.19B | 16.97 | -9.43 | -14.93% | -5.8% | -15.71% | 0.66 | |
 ANDE | 2.32B | 68.23 | 24.37 | -2.21% | 1.17% | 9.47% | 0.81 | |
 BIOX | 30.61M | 0.48 | -0.59 | -28.3% | -16.6% | -16.7% | 0.94 | |
 ADM | 37.6B | 78.02 | 34.99 | -6.15% | 1.34% | 4.72% | 0.37 | |
 INGR | 6.71B | 106.37 | 9.51 | -2.84% | 10.1% | 17.14% | 0.41 | |
 CWST | 5.3B | 84.58 | 704.83 | 17.95% | 0.38% | 0.46% | 0.79 | |
 BG | 24.46B | 126.05 | 25.62 | 32.42% | 0.85% | 4.28% | 0.97 |
Compare ALTO vs Peers
Alto Ingredients, Inc. (ALTO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ALTO Income Statement
Alto Ingredients, Inc. (ALTO) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.63B | 1.52B | 1.42B | 897.02M | 1.21B | 1.34B | 1.22B | 965.26M | 917.93M |
| Revenue Growth % | 0.46% | -7.16% | -5.97% | -37.05% | 34.66% | 10.57% | -8.44% | -21.07% | -4.9% |
| Cost of Goods Sold | 1.63B | 1.53B | 1.43B | 844.16M | 1.14B | 1.36B | 1.21B | 955.54M | 883.01M |
| COGS % of Revenue | 99.64% | 101% | 100.7% | 94.11% | 94.39% | 102.06% | 98.72% | 98.99% | 96.2% |
| Gross Profit | 5.93M▲ 0% | -15.16M▼ 355.7% | -9.94M▲ 34.5% | 52.86M▲ 631.9% | 67.78M▲ 28.2% | -27.55M▼ 140.6% | 15.65M▲ 156.8% | 9.72M▼ 37.9% | 34.91M▲ 259.1% |
| Gross Margin % | 0.36% | -1% | -0.7% | 5.89% | 5.61% | -2.06% | 1.28% | 1.01% | 3.8% |
| Gross Profit Growth % | -88.56% | -355.67% | 34.46% | 631.89% | 28.24% | -140.64% | 156.82% | -37.89% | 259.11% |
| Operating Expenses | 31.52M | 36.37M | 64.75M | 43.01M | 27.71M | 33.81M | 39.5M | 61.4M | 27.21M |
| OpEx % of Revenue | 1.93% | 2.4% | 4.54% | 4.79% | 2.29% | 2.53% | 3.23% | 6.36% | 2.96% |
| Selling, General & Admin | 31.52M | 36.37M | 35.45M | 31.98M | 29.18M | 28.08M | 32.66M | 29.74M | 27.21M |
| SG&A % of Revenue | 1.93% | 2.4% | 2.49% | 3.57% | 2.42% | 2.1% | 2.67% | 3.08% | 2.96% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 128K | 171K | 29.29M | 11.03M | -1.47M | 5.73M | 6.84M | 31.66M | 0 |
| Operating Income | -25.59M▲ 0% | -51.54M▼ 101.4% | -74.68M▼ 44.9% | 9.85M▲ 113.2% | 40.07M▲ 306.7% | -61.36M▼ 253.1% | -23.85M▲ 61.1% | -51.67M▼ 116.7% | 7.71M▲ 114.9% |
| Operating Margin % | -1.57% | -3.4% | -5.24% | 1.1% | 3.32% | -4.59% | -1.95% | -5.35% | 0.84% |
| Operating Income Growth % | -208.83% | -101.43% | -44.91% | 113.19% | 306.68% | -253.13% | 61.13% | -116.68% | 114.91% |
| EBITDA | 13.07M | -10.69M | -26.77M | 40.12M | 63.36M | -36.26M | -768K | -27.27M | 32.92M |
| EBITDA Margin % | 0.8% | -0.71% | -1.88% | 4.47% | 5.25% | -2.72% | -0.06% | -2.82% | 3.59% |
| EBITDA Growth % | -77.84% | -181.8% | -150.51% | 249.85% | 57.93% | -157.23% | 97.88% | -3450.39% | 220.74% |
| D&A (Non-Cash Add-back) | 38.65M | 40.85M | 47.91M | 30.27M | 23.29M | 25.09M | 23.08M | 24.41M | 25.22M |
| EBIT | -25.46M | -51.37M | -81.1M | 644K | 51.14M | -37.84M | -20.48M | -51.17M | 7.71M |
| Net Interest Income | -12.94M | -17.13M | -20.21M | -17.94M | -3.59M | -1.83M | -7.42M | -7.64M | -10.77M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 12.94M | 17.13M | 20.21M | 17.94M | 3.59M | 1.83M | 7.42M | 7.64M | 10.77M |
| Other Income/Expense | -12.81M | -16.96M | -26.62M | -27.15M | 7.48M | 21.69M | -4.06M | -7.14M | 5.01M |
| Pretax Income | -38.4M▲ 0% | -68.5M▼ 78.4% | -101.3M▼ 47.9% | -17.3M▲ 82.9% | 47.55M▲ 374.9% | -39.67M▼ 183.4% | -27.91M▲ 29.7% | -58.81M▼ 110.7% | 12.72M▲ 121.6% |
| Pretax Margin % | -2.35% | -4.52% | -7.11% | -1.93% | 3.94% | -2.97% | -2.28% | -6.09% | 1.39% |
| Income Tax | -321K | -562K | -20K | -17K | 1.47M | 1.93M | 97K | 173K | -621K |
| Effective Tax Rate % | 0.84% | 0.82% | 0.02% | 0.1% | 3.09% | -4.85% | -0.35% | -0.29% | -4.88% |
| Net Income | -34.96M▲ 0% | -60.27M▼ 72.4% | -88.95M▼ 47.6% | -15.12M▲ 83.0% | 46.08M▲ 404.9% | -41.6M▼ 190.3% | -28M▲ 32.7% | -58.98M▼ 110.6% | 13.34M▲ 122.6% |
| Net Margin % | -2.14% | -3.98% | -6.24% | -1.69% | 3.82% | -3.11% | -2.29% | -6.11% | 1.45% |
| Net Income Growth % | -2563.99% | -72.39% | -47.58% | 83.01% | 404.86% | -190.27% | 32.68% | -110.62% | 122.61% |
| Net Income (Continuing) | -38.07M | -67.94M | -101.28M | -17.28M | 46.08M | -41.6M | -28M | -58.98M | 13.34M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 27.26M | 19.6M | 7.26M | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.82▲ 0% | -1.39▼ 69.5% | -2.14▼ 54.0% | -0.29▲ 86.4% | 0.61▲ 310.3% | -0.58▼ 195.1% | -0.40▲ 31.0% | -0.82▼ 105.0% | 0.16▲ 119.5% |
| EPS Growth % | - | -69.51% | -53.96% | 86.45% | 310.34% | -195.08% | 31.03% | -105% | 119.51% |
| EPS (Basic) | -0.82 | -1.39 | -2.14 | -0.29 | 0.62 | -0.58 | -0.40 | -0.82 | 0.16 |
| Diluted Shares Outstanding | 42.74M | 43.38M | 47.38M | 58.61M | 72.22M | 71.94M | 73.34M | 73.48M | 75.66M |
| Basic Shares Outstanding | 42.62M | 43.38M | 47.38M | 58.61M | 71.1M | 71.94M | 73.34M | 73.48M | 74.51M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
ALTO Balance Sheet
Alto Ingredients, Inc. (ALTO) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 203.25M | 168.8M | 232.06M | 214.05M | 229.53M | 199.12M | 168.77M | 153.12M | 155.92M |
| Cash & Short-Term Investments | 49.49M | 26.63M | 19M | 47.67M | 50.61M | 36.46M | 30.01M | 35.47M | 25.67M |
| Cash Only | 49.49M | 26.63M | 19M | 47.67M | 50.61M | 36.46M | 30.01M | 35.47M | 25.67M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 81.09M | 68.25M | 74.31M | 43.49M | 86.89M | 68.66M | 58.73M | 58.22M | 62.57M |
| Days Sales Outstanding | 18.13 | 16.44 | 19.03 | 17.7 | 26.26 | 18.76 | 17.53 | 22.01 | 24.88 |
| Inventory | 61.55M | 57.82M | 60.6M | 37.92M | 54.37M | 66.63M | 52.61M | 49.91M | 0 |
| Days Inventory Outstanding | 13.81 | 13.79 | 15.42 | 16.4 | 17.41 | 17.84 | 15.91 | 19.07 | - |
| Other Current Assets | 7.84M | 13.63M | 76.63M | 84.07M | 37.65M | 27.38M | 27.42M | 9.52M | 67.67M |
| Total Non-Current Assets | 517.05M | 491.18M | 380.43M | 262.77M | 255.43M | 279.2M | 285.47M | 248.32M | 232.87M |
| Property, Plant & Equipment | 508.35M | 482.66M | 356.87M | 240.53M | 235.96M | 258.01M | 271.35M | 235.29M | 0 |
| Fixed Asset Turnover | 3.21x | 3.14x | 3.99x | 3.73x | 5.12x | 5.18x | 4.51x | 4.10x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 5.97M | 0 | 0 | 0 |
| Intangible Assets | 2.68M | 2.68M | 2.68M | 2.68M | 2.68M | 9.09M | 8.5M | 4.51M | 0 |
| Long-Term Investments | 359.68M | 286.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 6.02M | 5.84M | 20.88M | 19.56M | 16.79M | 6.14M | 5.63M | 8.52M | 232.87M |
| Total Assets | 720.3M▲ 0% | 659.98M▼ 8.4% | 612.5M▼ 7.2% | 476.82M▼ 22.2% | 484.95M▲ 1.7% | 478.32M▼ 1.4% | 454.24M▼ 5.0% | 401.44M▼ 11.6% | 388.79M▼ 3.2% |
| Asset Turnover | 2.27x | 2.30x | 2.33x | 1.88x | 2.49x | 2.79x | 2.69x | 2.40x | 2.36x |
| Asset Growth % | 1.7% | -8.37% | -7.2% | -22.15% | 1.71% | -1.37% | -5.03% | -11.62% | -3.15% |
| Total Current Liabilities | 90.71M | 231.86M | 160.4M | 86.93M | 69.6M | 78.02M | 65.29M | 57.8M | 59.07M |
| Accounts Payable | 39.74M | 48.18M | 29.28M | 13.05M | 23.25M | 28.11M | 20.75M | 20.37M | 14.51M |
| Days Payables Outstanding | 8.92 | 11.49 | 7.45 | 5.64 | 7.44 | 7.53 | 6.27 | 7.78 | 6 |
| Short-Term Debt | 20M | 146.67M | 63M | 25.53M | 0 | 0 | 0 | 0 | 21.56M |
| Deferred Revenue (Current) | 21.67M | 23.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.7M | 13.55M | 42.33M | 35.07M | 21.14M | 19.5M | 20M | 8.37M | 23M |
| Current Ratio | 2.24x | 0.73x | 1.45x | 2.46x | 3.30x | 2.55x | 2.59x | 2.65x | 2.64x |
| Quick Ratio | 1.56x | 0.48x | 1.07x | 2.03x | 2.52x | 1.70x | 1.78x | 1.79x | 2.64x |
| Cash Conversion Cycle | 23.03 | 18.74 | 27 | 28.45 | 36.22 | 29.07 | 27.16 | 33.3 | - |
| Total Non-Current Liabilities | 245.89M | 108.76M | 225.05M | 93.66M | 70.14M | 92.22M | 109.4M | 118.57M | 84.47M |
| Long-Term Debt | 221.09M | 84.84M | 180.79M | 71.81M | 50.36M | 68.36M | 82.1M | 92.9M | 63.03M |
| Capital Lease Obligations | 123K | 78K | 21.17M | 8.71M | 9.38M | 15.06M | 19.03M | 16.91M | 13.01M |
| Deferred Tax Liabilities | 224K | 251K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 24.68M | 23.83M | 23.09M | 13.13M | 10.39M | 8.8M | 8.27M | 8.75M | 8.43M |
| Total Liabilities | 336.6M | 340.62M | 385.45M | 180.58M | 139.74M | 170.23M | 174.68M | 176.38M | 143.54M |
| Total Debt | 241.81M | 231.56M | 268.42M | 108.23M | 63.65M | 87.27M | 105.46M | 114.67M | 97.6M |
| Net Debt | 192.32M | 204.93M | 249.43M | 60.57M | 13.04M | 50.81M | 75.44M | 79.2M | 71.92M |
| Debt / Equity | 0.63x | 0.73x | 1.18x | 0.37x | 0.18x | 0.28x | 0.38x | 0.51x | 0.40x |
| Debt / EBITDA | 18.51x | - | - | 2.70x | 1.00x | - | - | - | 2.96x |
| Net Debt / EBITDA | 14.72x | - | - | 1.51x | 0.21x | - | - | - | 2.18x |
| Interest Coverage | -1.97x | -3.00x | -4.01x | 0.04x | 14.26x | -20.71x | -2.76x | -6.69x | 0.72x |
| Total Equity | 383.7M▲ 0% | 319.37M▼ 16.8% | 227.04M▼ 28.9% | 296.24M▲ 30.5% | 345.21M▲ 16.5% | 308.09M▼ 10.8% | 279.56M▼ 9.3% | 225.06M▼ 19.5% | 245.24M▲ 9.0% |
| Equity Growth % | -8.26% | -16.77% | -28.91% | 30.47% | 16.53% | -10.75% | -9.26% | -19.49% | 8.97% |
| Book Value per Share | 8.98 | 7.36 | 4.79 | 5.05 | 4.78 | 4.28 | 3.81 | 3.06 | 3.24 |
| Total Shareholders' Equity | 356.44M | 299.77M | 219.78M | 296.24M | 345.21M | 308.09M | 279.56M | 225.06M | 245.24M |
| Common Stock | 44K | 46K | 56K | 72K | 73K | 75K | 76K | 77K | 77K |
| Retained Earnings | -568.46M | -630M | -720.21M | -736.6M | -691.78M | -734.64M | -763.91M | -824.17M | -812.09M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2.23M | -2.46M | -2.37M | -3.88M | -284K | 1.82M | 2.48M | 4.97M | 5.46M |
| Minority Interest | 27.26M | 19.6M | 7.26M | 0 | 0 | 0 | 0 | 0 | 0 |
ALTO Cash Flow Statement
Alto Ingredients, Inc. (ALTO) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 36.51M | 1.57M | -31.23M | 71.68M | 26.82M | 6.05M | 22.02M | -3.52M | 13.24M |
| Operating CF Margin % | 2.24% | 0.1% | -2.19% | 7.99% | 2.22% | 0.45% | 1.8% | -0.36% | 1.44% |
| Operating CF Growth % | -9.62% | -95.71% | -2094.06% | 329.55% | -62.58% | -77.45% | 264.11% | -115.99% | 476.17% |
| Net Income | -38.07M | -67.94M | -101.28M | -17.28M | 46.08M | -41.6M | -28M | -58.98M | 13.34M |
| Depreciation & Amortization | 38.65M | 40.85M | 47.91M | 30.27M | 23.29M | 25.09M | 23.08M | 24.41M | 25.22M |
| Stock-Based Compensation | 3.83M | 3.44M | 2.81M | 2.68M | 2.88M | 3.33M | 3.9M | 4.36M | 3.02M |
| Deferred Taxes | 169K | 27K | 2K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 5.43M | 8.03M | 37.66M | 19.24M | -32.24M | -12.34M | 19.34M | 16.73M | -11.89M |
| Working Capital Changes | 26.51M | 17.16M | -18.33M | 36.78M | -13.19M | 31.55M | 3.71M | 9.96M | -16.44M |
| Change in Receivables | 17.56M | 12.66M | -6.7M | 30.57M | -43.55M | 23.97M | 9.5M | 562K | 3.31M |
| Change in Inventory | 5.07M | 4.08M | -2.78M | 19.09M | -16.45M | -15.48M | 11.82M | 4.48M | -12.62M |
| Change in Payables | 3.86M | 63.47M | 0 | 0 | 0 | 28.11B | -12.55M | 9.95M | -2.83M |
| Cash from Investing | -50.44M | -15.15M | -3.28M | 23.32M | 27.12M | -37.66M | -33.03M | -13.47M | -7.43M |
| Capital Expenditures | -20.87M | -15.15M | -3.28M | -6.58M | -16.38M | -37.74M | -29.53M | -11.07M | -4.6M |
| CapEx % of Revenue | 1.28% | 1% | 0.23% | 0.73% | 1.36% | 2.83% | 2.41% | 1.15% | 0.5% |
| Acquisitions | -29.57M | 0 | 0 | 19.9M | 43.5M | -14.69M | -3.5M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -28.13M | -10M | 0 | 10M | 0 | 14.77M | 0 | -2.4M | -2.83M |
| Cash from Financing | -839K | -9.27M | 19.01M | -66.42M | -40M | 19.01M | 6.96M | 7.72M | -16.36M |
| Debt Issued (Net) | -6.39M | -11.69M | 9.53M | -147.75M | -37.61M | 26.77M | 12.61M | 8.99M | -15.09M |
| Equity Issued (Net) | 0 | 0 | 3.67M | 75.83M | 462K | -1.32M | -3.67M | 0 | 0 |
| Dividends Paid | -1.26M | -1.26M | -946K | 0 | -2.85M | -1.26M | -1.26M | -1.27M | -1.26M |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -1.32M | -3.67M | 0 | 0 |
| Other Financing | 6.82M | 3.69M | 6.76M | 5.5M | 0 | -5.17M | -714K | 0 | 0 |
| Net Change in Cash | -14.77M▲ 0% | -22.86M▼ 54.8% | -15.49M▲ 32.2% | 28.57M▲ 284.4% | 13.94M▼ 51.2% | -12.6M▼ 190.4% | -4.04M▲ 67.9% | -9.27M▼ 129.1% | -10.54M▼ 13.7% |
| Free Cash Flow | 15.64M▲ 0% | -13.59M▼ 186.9% | -34.51M▼ 154.0% | 65.1M▲ 288.7% | 10.44M▼ 84.0% | -31.7M▼ 403.7% | -7.51M▲ 76.3% | -14.59M▼ 94.3% | 8.65M▲ 159.3% |
| FCF Margin % | 0.96% | -0.9% | -2.42% | 7.26% | 0.86% | -2.37% | -0.61% | -1.51% | 0.94% |
| FCF Growth % | -26.3% | -186.86% | -153.96% | 288.65% | -83.97% | -403.68% | 76.32% | -94.34% | 159.29% |
| FCF per Share | 0.37 | -0.31 | -0.73 | 1.11 | 0.14 | -0.44 | -0.10 | -0.20 | 0.11 |
| FCF Conversion (FCF/Net Income) | -1.04x | -0.03x | 0.35x | -4.74x | 0.58x | -0.15x | -0.79x | 0.06x | 0.99x |
| Interest Paid | 11.13M | 15.15M | 18.76M | 17.47M | 4.12M | 2.93M | 10.38M | 0 | 0 |
| Taxes Paid | 5.61M | 743K | 0 | 0 | 448K | 2.26M | 324K | 0 | 0 |
ALTO Key Ratios
Alto Ingredients, Inc. (ALTO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 0.36% | -8.72% | -17.15% | -32.56% | -5.78% | 14.37% | -12.73% | -9.53% | -23.38% | 5.67% |
| Return on Invested Capital (ROIC) | 3.2% | -3.4% | -7.03% | -11.19% | 1.77% | 8.41% | -12.83% | -5.01% | -11.76% | 1.86% |
| Gross Margin | 3.19% | 0.36% | -1% | -0.7% | 5.89% | 5.61% | -2.06% | 1.28% | 1.01% | 3.8% |
| Net Margin | 0.09% | -2.14% | -3.98% | -6.24% | -1.69% | 3.82% | -3.11% | -2.29% | -6.11% | 1.45% |
| Debt / Equity | 0.48x | 0.63x | 0.73x | 1.18x | 0.37x | 0.18x | 0.28x | 0.38x | 0.51x | 0.40x |
| Interest Coverage | 1.00x | -1.97x | -3.00x | -4.01x | 0.04x | 14.26x | -20.71x | -2.76x | -6.69x | 0.72x |
| FCF Conversion | 28.47x | -1.04x | -0.03x | 0.35x | -4.74x | 0.58x | -0.15x | -0.79x | 0.06x | 0.99x |
| Revenue Growth | 36.4% | 0.46% | -7.16% | -5.97% | -37.05% | 34.66% | 10.57% | -8.44% | -21.07% | -4.9% |
ALTO SEC Filings & Documents
Alto Ingredients, Inc. (ALTO) SEC filings — annual & quarterly reports (10-K, 10-Q)
ALTO Frequently Asked Questions
Alto Ingredients, Inc. (ALTO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Alto Ingredients, Inc. (ALTO) reported $917.9M in revenue for fiscal year 2025. This represents a 6205% increase from $14.6M in 1998.
Alto Ingredients, Inc. (ALTO) saw revenue decline by 4.9% over the past year.
Yes, Alto Ingredients, Inc. (ALTO) is profitable, generating $13.3M in net income for fiscal year 2025 (1.5% net margin).
Dividend & Returns
Yes, Alto Ingredients, Inc. (ALTO) pays a dividend with a yield of 0.30%. This makes it attractive for income-focused investors.
Alto Ingredients, Inc. (ALTO) has a return on equity (ROE) of 5.7%. This is below average, suggesting room for improvement.
Alto Ingredients, Inc. (ALTO) generated $8.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More ALTO
Alto Ingredients, Inc. (ALTO) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates